Advertisement

Ads Placeholder
Loading...

Santen Pharmaceutical Co., Ltd.

SNPHY•PNK
Healthcare
Drug Manufacturers - General
$12.22
$0.74(6.45%)
U.S. Market is Open • 15:38

Santen Pharmaceutical Co., Ltd. (SNPHY) Stock Overview

Explore Santen Pharmaceutical Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.7B
P/E Ratio19.16
EPS (TTM)$0.58
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$10.09
3 Months$13.59
1 Year Target$10.65

SNPHY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Santen Pharmaceutical Co., Ltd. (SNPHY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.90, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.65.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.16 and a market capitalization of 3.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.09%
5-Day Change
4.45%
1-Month Change
10.91%
3-Month Change
6.88%
6-Month Change
3.51%
Year-to-Date (YTD) Change
6.88%
1-Year Change
20.57%
3-Year Change
35.66%
5-Year Change
-17.28%
All-Time (Max) Change
-14.21%

Contact Information

https://www.santen.com
81 6 7664 8621
Grand Front Osaka Tower A, Osaka, NaN, 530-8552

Company Facts

37,440 Employees
IPO DateAug 31, 2011
CountryJP
Actively Trading

Frequently Asked Questions